РRESS-RELEASE
| Issue | Title | |
| Vol 12, No 4 (2020) | The Eisai company has got approval by the Ministry of Health of the Russian Federation on the use of antiepileptic drug Fycompa® in children | Abstract PDF (Rus) |
| article Editorial | ||
| 1 - 1 of 1 Items | ||
Section Details
Popular articles
Vol 14, No 1 (2022)
The effect of benign epileptiform discharges of childhood on cognitive function, behavior and speech
Vol 14, No 1 (2022)
Vol 15, No 1 (2023)
Vol 8, No 4 (2016)
Vol 14, No 2 (2022)
Vol 9, No 1 (2017)
Keywords
EEG
Epilepsy
anticonvulsants
antiepileptic drugs
antiepileptic therapy
children
depression
drug-resistant epilepsy
efficacy
electroencephalography
epilepsy
juvenile myoclonic epilepsy
lamotrigine
levetiracetam
magnetic resonance imaging
perampanel
quality of life
seizures
treatment
valproic acid
video-EEG monitoring
117042, Moscow, Chechersky passage, 24
Tel.: +7(495)6495495
e-mail: info@irbis-1.ru
